Recent findings show that BAP1 suppresses prostate cancer progression by deubiquitinating and stabilizing PTEN, inhibiting the PI3K-AKT-mTOR pathway and suppressing trophoblastic EMT [14]. Here, PTEN is linked to prostate carcinoma.